Effect of hepatitis B x gene-overexpressed hepatocytes on the proliferation and activation of hepatic stellate cells and related mechanism

Tingyu REN; Hezhongrong NIE; Lijia XIAO; Fangnan LIN; Daming WANG; Chunli SONG; Yiwen ZHOU

doi:10.3969/j.issn.1001-5256.2021.07.017

Volume 37 Issue 7

Jul. 2021

Turn off MathJax

Article Contents

Article Navigation > Journal of Clinical Hepatology > 2021 > 37(7): 1561-1566

PDF( 3213 KB)

Effect of hepatitis B x gene-overexpressed hepatocytes on the proliferation and activation of hepatic stellate cells and related mechanism

DOI: 10.3969/j.issn.1001-5256.2021.07.017

1.
Department of Clinical Laboratory, Shenzhen Hospital, Southern Medical University, Shenzhen, Guangdong 518000, China
2.
Genetic Diagnosis Center, The First Hospital of Jilin University, Changchun 130012, China

Research funding:

National Natural Science Foundation of China (81974457);

National Natural Science Foundation of China (81702088);

Natural Science Foundation of Guangdong Province (2018A030313740);

Natural Science Foundation of Guangdong Province (2018A030310446);

Natural Science Foundation of Guangdong Province (2019A1515012079);

Medical Scientific Research Foundation of Guangdong Province (B2018013);

Seeding Program of Shenzhen Hospital of Southern Medical University (2018MM02);

Research Fund of Innovation and Technology Bureau of Baoan District (2019JD443)

Received Date: 2021-02-01
Accepted Date: 2021-03-24
Published Date: 2021-07-20

Abstract

Abstract

Objective To investigate the effect of hepatitis B virus (HBV) infection on the activation of hepatic stellate cells (HSCs) and its mechanism of action. Methods A total of 30 plasma samples of chronic hepatitis B patients, 42 plasma samples of hepatitis B cirrhosis patients, 30 plasma samples of hepatocellular carcinoma patients, and 18 plasma samples of the individuals undergoing physical examination were collected from November 2020 to January 2021, and ELISA was used to measure the content of hepatitis B X protein (HBx), transforming growth factor-β1 (TGFβ1), dopamine beta-hydroxylase (DBH), and hydroxyproline (HYP) in plasma and conditioned medium. LO2 cells were used to establish a cell line with stable overexpression of HBx (LO2-HBx) and negative control cells (LO2-con), and a conditioned medium was prepared for LO2-HBx, LO2-Con, and LO2 cells (Mock), respectively; human HSC cell line LX-2 was incubated and divided into LX-2/LO2-HBx, LX-2/LO2-con, and LX-2/Mock groups, and CCK-8 assay was used to measure the change in cell proliferation. LX-2 cells were stimulated by rhTGFβ1, and the cells in the LX-2/LO2-HBx group were treated with a TGFβ1 receptor inhibitor. Quantitative real-time PCR and Western blot were used to measure the expression of HBx in LO2 cells and the expression of alpha-smooth muscle actin (α-SMA), collagen type Ⅰ alpha 1 (Col1A1), DBH, and TGFβ1 in the above LX-2 cells. An analysis of variance was used for comparison between multiple groups, and the Bonferroni method was used for further comparison; the t-test was used for comparison between two groups; the Pearson method was used for correlation analysis. Results LO2-HBx stably expressed HBx protein and showed an increase in the content of TGFβ1 in supernatant (F=324.701, P < 0.01). The co-cultured LX-2/LO2-HBx group had a significant change in cell morphology, with the presence of cell shrinkage, extended cytoplasmic process, and reduced lipid droplets, and compared with the LX-2/LO2-con group, the LX-2/LO2-HBx group had significant increases in proliferative activity (P < 0.05) and the mRNA and protein expression levels of α-SMA and Col1A1 (mRNA: F=144.712 and 76.680, both P < 0.01; protein: F=234.142 and 528.708, both P < 0.001). The LX-2/LO2-HBx group had significant increases in the content of TGFβ1 (F=29.382, P < 0.01) and DBH (F=42.662, P < 0.01). With the increase in the stimulating concentration of rhTGFβ1, there were significant increases in the expression of α-SMA (F=1 794.031, P < 0.01), Col1A1 (F=91.340, P < 0.01), and DBH (F=2 501.011, P < 0.01), which reached the peak values at the rhTGFβ1 concentration of 10 ng/ml, and after a TGFβ1 receptor inhibitor was added to the conditioned medium, the LO2-HBx group had significant reductions in the expression of DBH and Col1A1 compared with the control group (t=3.603 and 5.798, both P < 0.05). Compared with the healthy control group, the chronic hepatitis B, liver cirrhosis, and hepatocellular carcinoma groups had significant increases in the plasma levels of TGFβ1 (F=51.188, P < 0.001), HBx (F=39.227, P < 0.001), DBH (F=34.431, P < 0.001), and HYP (F=16.211, P < 0.001), and a positive correlation was observed between plasma HBx and TGFβ1, between TGFβ1 and DBH, and between HYP and DBH (r= 0.931, 0.863, and 0.765, all P < 0.001). Conclusion HBx protein can promote the secretion of TGFβ1 in LO2 cells, induce the proliferation and activation of LX-2 cells, promote the development of liver fibrosis, and upregulate the expression of TGFβ1 and DBH in LX-2 cells, and rhTGFβ1 stimulation can induce the activation of LX-2 cells and the upregulation of DBH expression.
- Hepatitis B,
- Liver Cirrhosis,
- Hepatic Stellate Cells,
- HBV-X Protein

FullText(HTML)

References(16)

References

[1]	VITTAL A, GHANY MG. WHO guidelines for prevention, care and treatment of individuals infected with HBV: A US perspective[J]. Clin Liver Dis, 2019, 23(3): 417-432. DOI: 10.1016/j.cld.2019.04.008.
[2]	WANG M, XI D, NING Q. Virus-induced hepatocellular carcinoma with special emphasis on HBV[J]. Hepatol Int, 2017, 11(2): 171-180. DOI: 10.1007/s12072-016-9779-5.
[3]	BAGLIERI J, BRENNER DA, KISSELEVA T. The Role of fibrosis and liver-associated fibroblasts in the pathogenesis of hepatocellular carcinoma[J]. Int J Mol Sci, 2019, 20(7). DOI: 10.3390/ijms20071723.
[4]	ZHU J, LUO Z, PAN Y, et al. H19/miR-148a/USP4 axis facilitates liver fibrosis by enhancing TGF-β signaling in both hepatic stellate cells and hepatocytes[J]. J Cell Physiol, 2019, 234(6): 9698-9710. DOI: 10.1002/jcp.27656.
[5]	XU Y, ZHANG DQ, CHEN JM, et al. Effect of various cells on the activation of hepatic stellate cells in liver microenvironment[J]. J Clin Hepatol, 2019, 35(2): 424-430. DOI: 10.3969/j.issn.1001-5256.2019.02.042. 徐莹, 张定棋, 陈佳美, 等. 肝脏微环境中各种细胞对肝星状细胞活化的影响[J]. 临床肝胆病杂志, 2019, 35(2): 424-430. DOI: 10.3969/j.issn.1001-5256.2019.02.042.
[6]	EL-SERAG HB, MARRERO JA, RUDOLPH L, et al. Diagnosis and treatment of hepatocellular carcinoma[J]. Gastroenterology, 2008, 134(6): 1752-1763. DOI: 10.1053/j.gastro.2008.02.090.
[7]	REN CZ, HAO LS. Signal transduction involved in activation of hepatic stellate cells[J]. J Clin Hepatol, 2015, 31(3): 452-456. DOI: 10.3969/j.issn.1001-5256.2015.03.034. 任昌镇, 郝礼森. 肝星状细胞活化过程中的信号转导[J]. 临床肝胆病志, 2015, 31(3): 452-456. DOI: 10.3969/j.issn.1001-5256.2015.03.034.
[8]	WEN X, HUAN H, WANG X, et al. Sympathetic neurotransmitters promote the process of recellularization in decellularized liver matrix via activating the IL-6/Stat3 pathway[J]. Biomed Mater, 2016, 11(6): 065007. DOI: 10.1088/1748-6041/11/6/065007.
[9]	HUAN HB, WEN XD, CHEN XJ, et al. Sympathetic nervous system promotes hepatocarcinogenesis by modulating inflammation through activation of alpha1-adrenergic receptors of Kupffer cells[J]. Brain Behav Immun, 2017, 59: 118-134. DOI: 10.1016/j.bbi.2016.08.016.
[10]	KAMIMURA K, INOUE R, NAGOYA T, et al. Autonomic nervous system network and liver regeneration[J]. World J Gastroenterol, 2018, 24(15): 1616-1621. DOI: 10.3748/wjg.v24.i15.1616.
[11]	WANG L, ZHU L, WU K, et al. Mitochondrial general control of amino acid synthesis 5 like 1 regulates glutaminolysis, mammalian target of rapamycin complex 1 activity, and murine liver regeneration[J]. Hepatology, 2020, 71(2): 643-657. DOI: 10.1002/hep.30876.
[12]	OBEN JA, ROSKAMS T, YANG S, et al. Hepatic fibrogenesis requires sympathetic neurotransmitters[J]. Gut, 2004, 53(3): 438-445. DOI: 10.1136/gut.2003.026658.
[13]	COLL M, GENESCÀ J, RAURELL I, et al. Down-regulation of genes related to the adrenergic system may contribute to splanchnic vasodilation in rat portal hypertension[J]. J Hepatol, 2008, 49(1): 43-51. DOI: 10.1016/j.jhep.2008.03.015.
[14]	LI P, WU G. Roles of dietary glycine, proline, and hydroxyproline in collagen synthesis and animal growth[J]. Amino Acids, 2018, 50(1): 29-38. DOI: 10.1007/s00726-017-2490-6.
[15]	SRIVASTAVA AK, KHARE P, NAGAR HK, et al. Hydroxyproline: A potential biochemical marker and its role in the pathogenesis of different diseases[J]. Curr Protein Pept Sci, 2016, 17(6): 596-602. DOI: 10.2174/1389203717666151201192247.
[16]	SHIN SK, KIM KO, KIM SH, et al. Exogenous 8-hydroxydeoxyguanosine ameliorates liver fibrosis through the inhibition of Rac1-NADPH oxidase signaling[J]. J Gastroenterol Hepatol, 2020, 35(6): 1078-1087. DOI: 10.1111/jgh.14979.

Relative Articles

Supplements(0)

Cited By

Proportional views

Proportional views

通讯作者: 陈斌, bchen63@163.com

1.
沈阳化工大学材料科学与工程学院沈阳 110142

Figures(7) / Tables(1)

Get Citation

PDF

XML

Article Metrics

Article views (827) PDF downloads(59)

Effect of hepatitis B x gene-overexpressed hepatocytes on the proliferation and activation of hepatic stellate cells and related mechanism

DOI: 10.3969/j.issn.1001-5256.2021.07.017

Abstract

References

Proportional views

Catalog

通讯作者: 陈斌, bchen63@163.com

Article Metrics

Proportional views

Related

Effect of hepatitis B x gene-overexpressed hepatocytes on the proliferation and activation of hepatic stellate cells and related mechanism

DOI: 10.3969/j.issn.1001-5256.2021.07.017

Abstract

References

Proportional views

Catalog

通讯作者: 陈斌, bchen63@163.com

Article Metrics

Proportional views

Related

About Journal

Submission Guideline

Journal Online

Hepatobiliary College

Guidelines

Export File

Citation

Format

Content